€30 million AIB Seed Capital Fund to be located at NovaUCD
The AIB Seed Capital Fund, which is being equally funded by AIB and Enterprise Ireland is the first fund to be established under Enterprise Ireland’s €175 million Seed and Venture Capital Scheme 2007-2012.
Welcoming the establishment of the AIB Seed Capital Fund Dr Pat Frain, Director, NovaUCD said, “One of the challenges facing UCD is to accelerate the establishment of new ventures to commercialise innovative ideas and intellectual property arising from its growing research programmes. Two key issues in this regard are access to management expertise and the availability of seed funding.” He added, “This new fund is particularly welcomed since it will focus on early stage high-potential start-ups such as those spinning out from UCD research.”
The average initial investment to be made by the fund will be in the order of €250,000 but smaller investments of €100,000 will also be evaluated. The Fund has an economic life of seven years and it is expected that it will make in the region of 50 to 60 investments.
Media Contact
All latest news from the category: Business and Finance
This area provides up-to-date and interesting developments from the world of business, economics and finance.
A wealth of information is available on topics ranging from stock markets, consumer climate, labor market policies, bond markets, foreign trade and interest rate trends to stock exchange news and economic forecasts.
Newest articles
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…